How some bacteria grab iron and how cells tag proteins with arginine

Deciphering the Mechanisms of Pathogenic Ferrous Iron Acquisition and Eukaryotic Post-Translational Arginylation

NIH-funded research University of Maryland Baltimore County · NIH-11177307

This research explores how disease-causing bacteria take up iron and how cells add arginine to proteins to help scientists find new ways to prevent infections and treat related diseases.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore County NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-11177307 on NIH RePORTER

What this research studies

Researchers will examine bacterial iron uptake systems (like Feo, Bqs, and membrane ferric reductases) using biochemical, structural, and spectroscopic lab techniques and by testing effects in living models. They will also study how eukaryotic cells add arginine to proteins (post-translational arginylation) to understand its role in cell biology and disease. The work combines in vitro experiments with in vivo models to reveal molecular mechanisms that underlie bacterial virulence and protein regulation. Findings are intended to point toward possible targets for new antimicrobial strategies or therapies that address diseases linked to protein arginylation.

Who could benefit from this research

Good fit: This is laboratory and model-based research conducted at a university and does not enroll patients, so there are no patient candidates for participation.

Not a fit: People currently seeking treatment for infections should not expect direct or immediate clinical benefit from this basic science project.

Why it matters

Potential benefit: If successful, this work could identify new molecular targets that lead to antibiotics or therapies that better prevent or treat bacterial infections and diseases tied to protein modification.

How similar studies have performed: Previous basic research has mapped some bacterial iron pathways and protein-modifying enzymes, but translating those findings into therapies is still largely untested and remains an active research goal.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions CancersCardiovascular DiseasesDisease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.